Ptc Therapeutics Inc (PTCT)

Cost of Revenue

$19.92M

Quarterly · Period ending: · USD

PTCT logo

PTCT Cost of Revenue

Latest reported$19.92M
PTCT Quarterly Cost of Revenue (-$1.77M → $19.92M)
High-resolution chart · PNG

PTCT cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ptc Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
19,921,000
28,028,000
16,299,000
115,939,000
11,420,000
12,862,000
16,283,000
10,848,000
15,527,000
14,740,000
106,292,000
9,493,000
12,731,000
14,144,000
10,893,000
14,011,000
9,639,000
10,135,000
9,327,000
6,539,000
7,358,000
9,104,000
4,886,000
4,667,000
5,304,000
4,085,000
3,542,000
3,006,000
3,211,000
2,376,000
3,761,000
3,292,000
2,572,000
3,045,000
2,434,000
1,582,000
758,000
39,000
25,211,000
31,396,000
28,827,000
31,399,000
35,048,000
30,640,000
28,190,000
27,938,000
26,871,000
18,765,000
18,313,000
15,889,000
15,020,000
13,886,000
14,712,000
11,257,000
-721,555
-1,152,330
-1,520,764
-1,772,336
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.